University research records
King Edward Medical University
9 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →9 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to King Edward Medical University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–9 of 9 matching records. Counts update as records arrive.
Guideline-Directed Medical Therapy for Diabetic Kidney Disease: Advances in Primary and Secondary Prevention
January 19, 2026 · 3 citations · Open access
Open original record →Effectiveness of SGLT2 Inhibitors in Improving Functional Capacity and Reducing Hospitalizations in Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Randomized Controlled Trials
September 15, 2025 · 0 citations · Open access
Open original record →Evaluating the Clinical Outcomes of Empagliflozin in Heart Failure Patients With Preserved Ejection Fraction: A Systematic Review
May 13, 2025 · 0 citations · Open access
Open original record →Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
May 1, 2025 · 5 citations · Open access
Open original record →Efficacy and Safety of Pioglitazone Add‐On in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
May 1, 2025 · 10 citations · Open access
Open original record →Navigating the Crossroads: Understanding the Link Between Chronic Kidney Disease and Cardiovascular Health
December 30, 2023 · 33 citations · Open access
Open original record →Integrating Medicine and Pharmacology: The Burden of Heart Failure in Diabetes, Its Treatment Patterns and Consequences for Patient Quality of Life
December 28, 2023 · 0 citations · Open access
Open original record →SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
November 23, 2022 · 28 citations · Open access
Open original record →Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
November 7, 2019 · 21 citations · Open access
Open original record →